{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 15,
        "end": 26
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 32,
        "end": 35
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 67,
        "end": 79
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 94,
        "end": 105
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 32,
        "end": 48
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 52,
        "end": 56
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 0,
        "end": 48
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "19549911_9",
  "text": "Combination of fludarabine with SYK Inhibitor II or R406 increased cytotoxicity compared with fludarabine therapy alone ."
}
